329358-96-5

Upstream product

• 5815-08-7 tert-Butoxybis(dimethylamino)methane 
• 1212-53-9 methyl N-benzyloxycarbonylglycinate 

Downstream Products

• 1334628-88-4 C₂₀H₁₇NO₆ 
• 223718-30-7 3-(benzyloxycarbonyl)amino-7-hydroxy-8-methyl-2H-1-benzopyran-2-one 
• 1350883-35-0 C₂₅H₂₂N₂O₅ 
• 1083312-86-0 benzyl 7-hydroxy-8-methoxy-2-oxo-2H-chromen-3-ylcarbamate 
• 1083312-84-8 benzyl 7-hydroxy-2-oxo-8-phenyl-2H-chromen-3-ylcarbamate 
• 1083312-81-5 benzyl 7-hydroxy-5-methoxy-8-methyl-2-oxo-2H-chromen-3-ylcarbamate 
• 1083312-79-1 benzyl 7-hydroxy-8-methyl-2-oxo-6-propoxy-2H-chromen-3-ylcarbamate 

Relevant academic research and scientific papers

Exploiting polarity and chirality to probe the Hsp90 C-terminus

Inhibition of the Hsp90 C-terminus is an attractive therapeutic approach for the treatment of cancer. Novobiocin, the first Hsp90 C-terminal inhibitor identified, contains a synthetically complex noviose sugar that has limited the generation of structure-

5-protected aminopyrimidine compound, production method thereof and intermediate thereof

The present invention provides a production method of 5-aminopyrimidine compound represented by the formula (5) by reacting a glycine compound represented by the formula (1) with t-butoxybisdimethylaminomethane, dimethylformamidedimethylacetal or dimethyl